📜 Therapeutic Goods (Legislative Instruments) Notice (No. 4) 2026
NoticeSL 2026/1627 February 2026
Principal Act
This notice publishes the Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Simvastatin) Amendment Instrument 2026 on the Federal Register of Legislation, making it applicable as a law of Western Australia under the Therapeutic Goods Law Application Act 2024.
This impacts pharmacists and patients who rely on Simvastatin, as it relates to the management of medicine shortages and allows for potential substitutions under specific conditions. Healthcare providers need to be aware of the changes.
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.